These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8371070)

  • 1. Acetaldehyde adducts and autoantibodies against VLDL and LDL in alcoholics.
    Wehr H; Rodo M; Lieber CS; Baraona E
    J Lipid Res; 1993 Jul; 34(7):1237-44. PubMed ID: 8371070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
    Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies made against a formaldehyde-protein adduct cross react with an acetaldehyde-protein adduct. Implications for the origin of antibodies in human serum which recognize acetaldehyde-protein adducts.
    Pietrzak ER; Shanley BC; Kroon PA
    Alcohol Alcohol; 1995 May; 30(3):373-8. PubMed ID: 7545992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of VLDL apoprotein B by acetaldehyde alters apoprotein B metabolism.
    Kervinen K; Hörkkö S; Beltz WF; Kesäniemi A
    Alcohol; 1995; 12(3):189-94. PubMed ID: 7639949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response to acetaldehyde adducts in alcoholic patients.
    Hoerner M; Behrens UJ; Worner T; Lieber CS
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):3-12. PubMed ID: 3099350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-low-density lipoprotein antibodies in alcoholics without and with liver disease and in social drinkers.
    Wehr H; Milewski B; Pozniak M; Rodo M
    Alcohol Alcohol; 1997; 32(1):43-9. PubMed ID: 9131891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein changes during abstinence in chronic alcoholics.
    Weidman SW; Beard JD; Sabesin SM
    Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
    Arad Y; Ramakrishnan R; Ginsberg HN
    J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to low density lipoprotein used for the study of low- and very-low-density lipoproteins, in "ELISA" and immunoprecipitation technics.
    Salmon S; Goldstein S; Pastier D; Theron L; Berthelier M; Ayrault-Jarrier M; Dubarry M; Rebourcet R; Pau B
    Biochem Biophys Res Commun; 1984 Dec; 125(2):704-11. PubMed ID: 6083790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple changes in apoprotein B containing lipoproteins after ethanol withdrawal in alcoholic men.
    Kervinen K; Savolainen MJ; Kesäniemi YA
    Ann Med; 1991 Oct; 23(4):407-13. PubMed ID: 1930937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between alcohol intake and immunoglobulin a immunoreactivity with acetaldehyde-modified bovine serum albumin.
    Worrall S; de Jersey J; Wilce PA; Seppä K; Hurme L; Sillanaukee P
    Alcohol Clin Exp Res; 1996 Aug; 20(5):836-40. PubMed ID: 8865957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum levels of anti-low-density lipoprotein-acetaldehyde-adduct antibody and aldehyde dehydrogenase 2 heterozygotes in patients with alcoholic liver injury.
    Nagata N; Watanabe N; Tsuda M; Tsukamoto H; Matsuzaki S
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):24S-28S. PubMed ID: 10235274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice.
    Wang N; Arai T; Ji Y; Rinninger F; Tall AR
    J Biol Chem; 1998 Dec; 273(49):32920-6. PubMed ID: 9830042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts.
    Hoerner M; Behrens UJ; Worner TM; Blacksberg I; Braly LF; Schaffner F; Lieber CS
    Hepatology; 1988; 8(3):569-74. PubMed ID: 3371872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum lipoproteins in chronic alcoholics. Changes in HDL, VLDL and LDL as a function of the degree of hepatic involvement].
    Peynet J; Legrand A; Techenet P; Isal JP; Guillausseau PJ; Rousselet F
    Nouv Presse Med; 1982 Oct; 11(43):3179-83. PubMed ID: 7177834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.